Medrx Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY140.53 |
Market Cap |
JPY7.22 B |
Shares Outstanding |
12.71 M |
Public Float |
8.66 M |
Address |
431-7 Nishiyama Higashikagawa Kagawa 769 Japan |
Employees | - |
Website | http://www.medrx.co.jp |
Updated | 07/08/2019 |
Medrx Co. Ltd. engages in the business of pharmaceutical drug development based on the transdermal absorption. It develops new value-added medicines by the drug formulation technology based on ILTS (Ionic Liquid Transdermal System), a unique technologies using ionic liquid. The company was founded by Masayoshi Matsumura on January 15, 2002 and is headquartered in Higashikagawa, Japan. |